Paul Fortin

CHU de Québec - Université Laval, Canada

AbbVie (Consultant/Advisory Board)AstraZeneca (Consultant/Advisory Board)Lilly (Consultant/Advisory Board)

Poster(s):

• (P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine

• (P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus